• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

香港和多伦多 2003 年 SARS 爆发的流行病学文献分析:时间分层回顾。

Anatomy of the epidemiological literature on the 2003 SARS outbreaks in Hong Kong and Toronto: a time-stratified review.

机构信息

INSERM, U707, Paris, France.

出版信息

PLoS Med. 2010 May 4;7(5):e1000272. doi: 10.1371/journal.pmed.1000272.

DOI:10.1371/journal.pmed.1000272
PMID:20454570
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2864302/
Abstract

BACKGROUND

Outbreaks of emerging infectious diseases, especially those of a global nature, require rapid epidemiological analysis and information dissemination. The final products of those activities usually comprise internal memoranda and briefs within public health authorities and original research published in peer-reviewed journals. Using the 2003 severe acute respiratory syndrome (SARS) epidemic as an example, we conducted a comprehensive time-stratified review of the published literature to describe the different types of epidemiological outputs.

METHODS AND FINDINGS

We identified and analyzed all published articles on the epidemiology of the SARS outbreak in Hong Kong or Toronto. The analysis was stratified by study design, research domain, data collection, and analytical technique. We compared the SARS-case and matched-control non-SARS articles published according to the timeline of submission, acceptance, and publication. The impact factors of the publishing journals were examined according to the time of publication of SARS articles, and the numbers of citations received by SARS-case and matched-control articles submitted during and after the epidemic were compared. Descriptive, analytical, theoretical, and experimental epidemiology concerned, respectively, 54%, 30%, 11%, and 6% of the studies. Only 22% of the studies were submitted, 8% accepted, and 7% published during the epidemic. The submission-to-acceptance and acceptance-to-publication intervals of the SARS articles submitted during the epidemic period were significantly shorter than the corresponding intervals of matched-control non-SARS articles published in the same journal issues (p<0.001 and p<0.01, respectively). The differences of median submission-to-acceptance intervals and median acceptance-to-publication intervals between SARS articles and their corresponding control articles were 106.5 d (95% confidence interval [CI] 55.0-140.1) and 63.5 d (95% CI 18.0-94.1), respectively. The median numbers of citations of the SARS articles submitted during the epidemic and over the 2 y thereafter were 17 (interquartile range [IQR] 8.0-52.0) and 8 (IQR 3.2-21.8), respectively, significantly higher than the median numbers of control article citations (15, IQR 8.5-16.5, p<0.05, and 7, IQR 3.0-12.0, p<0.01, respectively).

CONCLUSIONS

A majority of the epidemiological articles on SARS were submitted after the epidemic had ended, although the corresponding studies had relevance to public health authorities during the epidemic. To minimize the lag between research and the exigency of public health practice in the future, researchers should consider adopting common, predefined protocols and ready-to-use instruments to improve timeliness, and thus, relevance, in addition to standardizing comparability across studies. To facilitate information dissemination, journal managers should reengineer their fast-track channels, which should be adapted to the purpose of an emerging outbreak, taking into account the requirement of high standards of quality for scientific journals and competition with other online resources.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef36/2864302/e9a853e14c94/pmed.1000272.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef36/2864302/c67352b8b195/pmed.1000272.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef36/2864302/7bf94913d153/pmed.1000272.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef36/2864302/28704e508ed5/pmed.1000272.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef36/2864302/c2aaae4d7b50/pmed.1000272.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef36/2864302/8f8dec48ea4b/pmed.1000272.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef36/2864302/e9a853e14c94/pmed.1000272.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef36/2864302/c67352b8b195/pmed.1000272.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef36/2864302/7bf94913d153/pmed.1000272.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef36/2864302/28704e508ed5/pmed.1000272.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef36/2864302/c2aaae4d7b50/pmed.1000272.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef36/2864302/8f8dec48ea4b/pmed.1000272.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef36/2864302/e9a853e14c94/pmed.1000272.g006.jpg
摘要

背景

新出现传染病的爆发,特别是那些具有全球性的传染病,需要进行快速的流行病学分析和信息传播。这些活动的最终产物通常包括公共卫生部门内部的备忘录和简报,以及在同行评议期刊上发表的原始研究。以 2003 年严重急性呼吸综合征(SARS)疫情为例,我们对已发表的文献进行了全面的时间分层综述,以描述不同类型的流行病学产出。

方法和发现

我们确定并分析了香港或多伦多 SARS 疫情的所有已发表流行病学文章。根据研究设计、研究领域、数据收集和分析技术对分析进行分层。我们比较了根据提交、接受和发表时间线发表的 SARS 病例和匹配对照非 SARS 文章。根据 SARS 文章发表时间检查了出版期刊的影响因素,并比较了疫情期间和之后提交的 SARS 病例和匹配对照文章的引用次数。描述性、分析性、理论性和实验性流行病学分别占研究的 54%、30%、11%和 6%。只有 22%的研究在疫情期间提交,8%的研究被接受,7%的研究发表。疫情期间提交的 SARS 文章的提交至接受和接受至发表的时间间隔明显短于同期发表的匹配对照非 SARS 文章(p<0.001 和 p<0.01)。SARS 文章与相应对照文章的中位提交至接受间隔和中位接受至发表间隔差异分别为 106.5 天(95%置信区间 [CI] 55.0-140.1)和 63.5 天(95% CI 18.0-94.1)。疫情期间和之后 2 年提交的 SARS 文章的中位引用次数分别为 17(四分位距 [IQR] 8.0-52.0)和 8(IQR 3.2-21.8),明显高于对照文章的中位引用次数(15,IQR 8.5-16.5,p<0.05 和 7,IQR 3.0-12.0,p<0.01)。

结论

大多数关于 SARS 的流行病学文章都是在疫情结束后提交的,尽管这些相应的研究在疫情期间与公共卫生部门有关。为了减少未来研究与公共卫生实践紧迫性之间的差距,研究人员应考虑采用通用的、预先确定的方案和即用型工具,以提高及时性,从而提高相关性,同时还应标准化研究之间的可比性。为了促进信息传播,期刊管理人员应重新设计其快速通道渠道,该渠道应适应突发疫情的目的,同时考虑到对科学期刊高标准质量的要求以及与其他在线资源的竞争。

相似文献

1
Anatomy of the epidemiological literature on the 2003 SARS outbreaks in Hong Kong and Toronto: a time-stratified review.香港和多伦多 2003 年 SARS 爆发的流行病学文献分析:时间分层回顾。
PLoS Med. 2010 May 4;7(5):e1000272. doi: 10.1371/journal.pmed.1000272.
2
Publication times, impact factors, and advance online publication in ophthalmology journals.眼科期刊的出版时间、影响因子和预印本出版
Ophthalmology. 2013 Aug;120(8):1697-701. doi: 10.1016/j.ophtha.2013.01.044. Epub 2013 Apr 23.
3
Publishing in pandemic times: A bibliometric analysis of early medical publications on Kawasaki-like disease (MIS-C, PIMS-TS) related to SARS-CoV-2.大流行时期的出版:与 SARS-CoV-2 相关的川崎病样疾病(MIS-C、PIMS-TS)早期医学出版物的文献计量分析。
Arch Pediatr. 2021 Aug;28(6):464-469. doi: 10.1016/j.arcped.2021.05.002. Epub 2021 May 28.
4
Scientific publications in anesthesiology journals from mainland China, Taiwan, and Hong Kong: a 10-year survey of the literature.中国大陆、台湾和香港地区麻醉学期刊的科学出版物:文献 10 年调查。
Anesth Analg. 2010 Mar 1;110(3):918-21. doi: 10.1213/ANE.0b013e3181c793ee. Epub 2009 Dec 2.
5
Predictors of publication: characteristics of submitted manuscripts associated with acceptance at major biomedical journals.发表的预测因素:与在主要生物医学期刊上被录用相关的投稿稿件特征
Med J Aust. 2006 Jun 19;184(12):621-6. doi: 10.5694/j.1326-5377.2006.tb00418.x.
6
Time from submission to publication in plastic surgery journals: The story of accepted manuscripts.整形外科期刊投稿到发表的时间:已接受稿件的故事。
J Plast Reconstr Aesthet Surg. 2020 Feb;73(2):383-390. doi: 10.1016/j.bjps.2019.09.029. Epub 2019 Oct 1.
7
Characteristics and fate of orthodontic articles submitted for publication: An exploratory study of the American Journal of Orthodontics and Dentofacial Orthopedics.提交发表的正畸学文章的特征与命运:《美国正畸与牙颌面正畸杂志》的一项探索性研究
Am J Orthod Dentofacial Orthop. 2015 Jun;147(6):680-90. doi: 10.1016/j.ajodo.2015.01.020.
8
What is submitted and what gets accepted in Indian Pediatrics: analysis of submissions, review process, decision making, and criteria for rejection.在《印度儿科学》上提交的内容与被接受的内容:投稿分析、评审过程、决策制定及退稿标准
Indian Pediatr. 2006 Jun;43(6):479-89.
9
Assessing the evolution of scientific publications in orthopedics journals from mainland China, Hong Kong, and Taiwan: a 12-year survey of the literature.评估中国大陆、香港和台湾地区骨科期刊科学出版物的发展:一项为期12年的文献调查。
J Orthop Surg Res. 2016 Jun 17;11(1):69. doi: 10.1186/s13018-016-0404-z.
10
Impact of study outcome on submission and acceptance metrics for peer reviewed medical journals: six year retrospective review of all completed GlaxoSmithKline human drug research studies.研究结果对同行评审医学期刊投稿与录用指标的影响:葛兰素史克所有已完成的人体药物研究的六年回顾性分析
BMJ. 2017 Apr 21;357:j1726. doi: 10.1136/bmj.j1726.

引用本文的文献

1
Effect of vaccine dose intervals: Considering immunity levels, vaccine efficacy, and strain variants for disease control strategy.疫苗接种间隔的效果:考虑免疫水平、疫苗效力和疾病控制策略的菌株变异。
PLoS One. 2024 Sep 19;19(9):e0310152. doi: 10.1371/journal.pone.0310152. eCollection 2024.
2
Changes in health communication in the age of COVID-19: A study on the dissemination of preprints to the public.新冠疫情时代的健康传播变化:预印本向公众传播研究。
Front Public Health. 2023 Feb 8;11:1078115. doi: 10.3389/fpubh.2023.1078115. eCollection 2023.
3
The Race for ACE: Targeting Angiotensin-Converting Enzymes (ACE) in SARS-CoV-2 Infection.

本文引用的文献

1
Patient-oriented pandemic influenza research.以患者为导向的大流行性流感研究。
Lancet. 2009 Jun 20;373(9681):2085-6. doi: 10.1016/S0140-6736(09)61131-4.
2
Global trends in emerging infectious diseases.新发传染病的全球趋势。
Nature. 2008 Feb 21;451(7181):990-3. doi: 10.1038/nature06536.
3
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.《加强流行病学观察性研究报告(STROBE)声明》:观察性研究报告指南
ACE 之争:靶向 SARS-CoV-2 感染中的血管紧张素转化酶(ACE)。
J Renin Angiotensin Aldosterone Syst. 2022 May 27;2022:2549063. doi: 10.1155/2022/2549063. eCollection 2022.
4
Openness, Integrity, Inclusion, and Innovation in Scholarly Communication: Competing or Complementary Forces?学术交流中的开放性、诚信、包容性与创新性:相互竞争还是相辅相成的力量?
Front Res Metr Anal. 2022 Jan 3;6:767869. doi: 10.3389/frma.2021.767869. eCollection 2021.
5
Over-promotion and caution in abstracts of preprints during the COVID-19 crisis.新冠疫情危机期间预印本摘要中的过度宣传与谨慎态度。
Learn Publ. 2021 Jul 21;34(4):622-636. doi: 10.1002/leap.1411.
6
Ontario's COVID-19 Modelling Consensus Table: mobilizing scientific expertise to support pandemic response.安大略省 COVID-19 模型共识表:调动科学专业知识以支持大流行应对。
Can J Public Health. 2021 Oct;112(5):799-806. doi: 10.17269/s41997-021-00559-8. Epub 2021 Aug 30.
7
Delays in reporting and publishing trial results during pandemics: cross sectional analysis of 2009 H1N1, 2014 Ebola, and 2016 Zika clinical trials.大流行期间临床试验结果报告和发表的延迟:对 2009 年 H1N1、2014 年埃博拉和 2016 年寨卡临床试验的横断面分析。
BMC Med Res Methodol. 2021 Jun 8;21(1):120. doi: 10.1186/s12874-021-01324-8.
8
Outbreaks of publications about emerging infectious diseases: the case of SARS-CoV-2 and Zika virus.新发传染病出版物的爆发:以 SARS-CoV-2 和寨卡病毒为例。
BMC Med Res Methodol. 2021 Mar 11;21(1):50. doi: 10.1186/s12874-021-01244-7.
9
Deciphering the SSR incidences across viral members of Coronaviridae family.解析冠状病毒科各病毒成员中的 SSR 事件。
Chem Biol Interact. 2020 Nov 1;331:109226. doi: 10.1016/j.cbi.2020.109226. Epub 2020 Sep 21.
10
Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009.大流行期间富有同情心的药物(滥用):2009 年 COVID-19 疫情带来的启示。
BMC Med. 2020 Aug 21;18(1):265. doi: 10.1186/s12916-020-01732-5.
PLoS Med. 2007 Oct 16;4(10):e296. doi: 10.1371/journal.pmed.0040296.
4
Extremely low exposure of a community to severe acute respiratory syndrome coronavirus: false seropositivity due to use of bacterially derived antigens.社区人群严重急性呼吸综合征冠状病毒暴露水平极低:因使用细菌衍生抗原导致假血清阳性
J Virol. 2006 Sep;80(18):8920-8. doi: 10.1128/JVI.00649-06.
5
The Global Public Health Intelligence Network and early warning outbreak detection: a Canadian contribution to global public health.全球公共卫生情报网络与早期疫情预警:加拿大对全球公共卫生的贡献。
Can J Public Health. 2006 Jan-Feb;97(1):42-4. doi: 10.1007/BF03405213.
6
Real-time estimates in early detection of SARS.SARS早期检测中的实时估计。
Emerg Infect Dis. 2006 Jan;12(1):110-3. doi: 10.3201/eid1201.050593.
7
Can routine laboratory tests discriminate between severe acute respiratory syndrome and other causes of community-acquired pneumonia?常规实验室检查能否区分严重急性呼吸综合征与社区获得性肺炎的其他病因?
Clin Infect Dis. 2005 Apr 15;40(8):1079-86. doi: 10.1086/428577. Epub 2005 Mar 16.
8
The use of an herbal formula by hospital care workers during the severe acute respiratory syndrome epidemic in Hong Kong to prevent severe acute respiratory syndrome transmission, relieve influenza-related symptoms, and improve quality of life: a prospective cohort study.香港严重急性呼吸系统综合症疫情期间医院医护人员使用中药配方预防严重急性呼吸系统综合症传播、缓解流感相关症状及改善生活质量的前瞻性队列研究。
J Altern Complement Med. 2005 Feb;11(1):49-55. doi: 10.1089/acm.2005.11.49.
9
Modelling strategies for controlling SARS outbreaks.控制非典疫情的建模策略。
Proc Biol Sci. 2004 Nov 7;271(1554):2223-32. doi: 10.1098/rspb.2004.2800.
10
The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients.2003年香港严重急性呼吸综合征疫情的流行病学:对1755例患者的分析。
Ann Intern Med. 2004 Nov 2;141(9):662-73. doi: 10.7326/0003-4819-141-9-200411020-00006.